The iRR6 model refines risk stratification for intermediate-1 myelofibrosis patients, incorporating ruxolitinib dosing, spleen reduction, and transfusion needs. Validation in an external cohort ...
BEIJING (Reuters) -Chinese AI developer DeepSeek has released its "experimental" latest model, which it said was more efficient to train and better at processing long sequences of text than previous ...
China's DeepSeek has launched a new AI model called DeepSeek-V3.2-Exp. The new model comes with the new DeepSeek Sparse Attention technology which the company says is “designed to explore and validate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results